Suppr超能文献

对p53有反应的微小RNA 192和215能够诱导细胞周期停滞。

p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

作者信息

Braun Christian J, Zhang Xin, Savelyeva Irina, Wolff Sonja, Moll Ute M, Schepeler Troels, Ørntoft Torben F, Andersen Claus L, Dobbelstein Matthias

机构信息

Department of Molecular Oncology, Göttingen Center of Molecular Biosciences, University of Göttingen, Göttingen, Germany.

出版信息

Cancer Res. 2008 Dec 15;68(24):10094-104. doi: 10.1158/0008-5472.CAN-08-1569.

Abstract

microRNAs provide a novel layer of regulation for gene expression by interfering with the stability and/or translation of specific target mRNAs. Overall levels of microRNAs are frequently down-regulated in cancer cells, and reducing general microRNA processing increases cancerogenesis in transgenic models, suggesting that at least some microRNAs might act as effectors in tumor suppression. Accordingly, the tumor suppressor p53 up-regulates miR-34a, a microRNA that contributes to apoptosis and acute senescence. Here, we used array hybridization to find that p53 induces two additional, mutually related clusters of microRNAs, leading to the up-regulation of miR-192, miR-194, and miR-215. The same microRNAs were detected at high levels in normal colon tissue but were severely reduced in many colon cancer samples. On the other hand, miR-192 and its cousin miR-215 can each contribute to enhanced CDKN1A/p21 levels, colony suppression, cell cycle arrest, and cell detachment from a solid support. These effects were partially dependent on the presence of wild-type p53. Antagonizing endogenous miR-192 attenuated 5-fluorouracil-induced accumulation of p21. Hence, miR-192 and miR-215 can act as effectors as well as regulators of p53; they seem to suppress cancerogenesis through p21 accumulation and cell cycle arrest.

摘要

微小RNA通过干扰特定靶标mRNA的稳定性和/或翻译为基因表达提供了一层新的调控机制。癌细胞中微小RNA的总体水平经常下调,在转基因模型中减少一般的微小RNA加工会增加肿瘤发生,这表明至少一些微小RNA可能作为肿瘤抑制的效应因子。因此,肿瘤抑制因子p53上调miR-34a,一种有助于细胞凋亡和急性衰老的微小RNA。在这里,我们使用阵列杂交发现p53诱导另外两个相互关联的微小RNA簇,导致miR-192、miR-194和miR-215上调。在正常结肠组织中可检测到高水平的相同微小RNA,但在许多结肠癌样本中则严重减少。另一方面,miR-192及其同源物miR-215各自可促进CDKN1A/p21水平升高、集落抑制、细胞周期停滞以及细胞从固体支持物上脱离。这些效应部分依赖于野生型p53的存在。拮抗内源性miR-192可减弱5-氟尿嘧啶诱导的p21积累。因此,miR-192和miR-215既可以作为效应因子,也可以作为p53的调节因子;它们似乎通过p21积累和细胞周期停滞来抑制肿瘤发生。

相似文献

引用本文的文献

2
The emerging role of miRNAs in biological aging and age-related diseases.微小RNA在生物衰老及与年龄相关疾病中的新作用。
Noncoding RNA Res. 2025 May 5;13:131-152. doi: 10.1016/j.ncrna.2025.05.002. eCollection 2025 Aug.

本文引用的文献

8
p53 enters the microRNA world.p53进入了微小RNA的世界。
Cancer Cell. 2007 Nov;12(5):414-8. doi: 10.1016/j.ccr.2007.10.028.
9
Tiny actors, great roles: microRNAs in p53's service.小角色,大作用:为p53服务的微小RNA
Cell Cycle. 2007 Nov 1;6(21):2656-61. doi: 10.4161/cc.6.21.4915. Epub 2007 Aug 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验